These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36171121)

  • 1. Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal Antibodies.
    Shimizu A; Shirai I; Ogawa K; Miura A; Haruhara K; Oshiro K; Hamaguchi A; Yokote S; Okabe M; Ueda H; Tsuboi N; Ikeda M; Yokoo T
    Intern Med; 2022 Dec; 61(24):3703-3708. PubMed ID: 36171121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regen-COV-2 Antibody Cocktail Mediated Clearance of SARS-COV-2 in an Immunocompromised Patient.
    Basheer M; Saad E; Milhem F; Budman D; Assy N
    Isr Med Assoc J; 2022 Nov; 24(11):695-696. PubMed ID: 36436032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.
    Taha Y; Wardle H; Evans AB; Hunter ER; Marr H; Osborne W; Bashton M; Smith D; Burton-Fanning S; Schmid ML; Duncan CJA
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):85. PubMed ID: 34969393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    O'Brien MP; Forleo-Neto E; Musser BJ; Isa F; Chan KC; Sarkar N; Bar KJ; Barnabas RV; Barouch DH; Cohen MS; Hurt CB; Burwen DR; Marovich MA; Hou P; Heirman I; Davis JD; Turner KC; Ramesh D; Mahmood A; Hooper AT; Hamilton JD; Kim Y; Purcell LA; Baum A; Kyratsous CA; Krainson J; Perez-Perez R; Mohseni R; Kowal B; DiCioccio AT; Stahl N; Lipsich L; Braunstein N; Herman G; Yancopoulos GD; Weinreich DM;
    N Engl J Med; 2021 Sep; 385(13):1184-1195. PubMed ID: 34347950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
    Drouin AC; Theberge MW; Liu SY; Smither AR; Flaherty SM; Zeller M; Geba GP; Reynaud P; Rothwell WB; Luk AP; Tian D; Boisen ML; Branco LM; Andersen KG; Robinson JE; Garry RF; Fusco DN
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34201591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of casirivimab/imdevimab administration in a SARS-CoV-2 positive maintenance dialysis patient in Japan.
    Terakawa K; Katagiri D; Shimada K; Sato L; Takano H
    CEN Case Rep; 2022 Aug; 11(3):328-332. PubMed ID: 35000134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series.
    Boeckel GR; Hölscher SD; Bürger C; Jacob T; Krekeler C; Shumilov E; Reicherts C; Bleckmann A; Lenz G; Vollenberg R; Tepasse PR
    Curr Oncol; 2022 Mar; 29(4):2312-2325. PubMed ID: 35448162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and Disease Relapses in Children with Nephrotic Syndrome.
    Angeletti A; Bruschi M; Bianchin S; Bonato I; Montobbio C; Verrina E; Lugani F; Cravedi P; Ghiggeri GM
    Clin J Am Soc Nephrol; 2021 Jun; 16(6):937-938. PubMed ID: 34117084
    [No Abstract]   [Full Text] [Related]  

  • 9. Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
    Stein D; Oviedo-Orta E; Kampman WA; McGinniss J; Betts G; McDermott M; Holly B; Lancaster JM; Braunstein N; Yancopoulos GD; Weinreich DM
    Clin Infect Dis; 2022 Aug; 75(1):e509-e515. PubMed ID: 34971385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of pregnant patients treated with REGEN-COV during the COVID-19 pandemic.
    Levey NH; Forrest AD; Spielman DW; Easley KA; Dude CM; Badell ML
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100673. PubMed ID: 35671984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous REGEN-COV antibody administration in a community pharmacy.
    Dougherty TS; McBride J; Barnett CL; Gabriel WM
    J Am Pharm Assoc (2003); 2023; 63(3):961-966. PubMed ID: 36710148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia.
    Palomba E; Carrabba M; Zuglian G; Alagna L; Saltini P; Fortina V; Hu C; Bandera A; Fabio G; Gori A; Muscatello A
    Int J Infect Dis; 2021 Sep; 110():338-340. PubMed ID: 34332085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report.
    Hussein MH; Alabdaljabar MS; Alfagyh N; Badran M; Alamiri K
    BMC Nephrol; 2021 Dec; 22(1):420. PubMed ID: 34965863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies.
    Hagihara M; Hayashi H; Nakashima S; Imai Y; Nakano H; Uchida T; Inoue M; Sakai-Tagawa Y; Ito M; Yamayoshi S; Iwatsuki-Horimoto K; Suzuki Y; Kawaoka Y
    Intern Med; 2024 Jan; ():. PubMed ID: 38171874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting.
    Belote A; Reece S; Robinson S; Jensen H; CarlLee S; Clark M; Parnell S; Geels C; Newton J
    Monoclon Antib Immunodiagn Immunother; 2022 Aug; 41(4):210-213. PubMed ID: 35920868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19.
    Miyazato Y; Yamamoto K; Nakaya Y; Morioka S; Takeuchi JS; Takamatsu Y; Maeda K; Kimura M; Sugiura W; Mitsuya H; Yano M; Ohmagari N
    J Infect Chemother; 2022 Jul; 28(7):991-994. PubMed ID: 35337728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients.
    Dioverti MV; Gaston DC; Morris CP; Huff CA; Jain T; Jones R; Anders V; Lederman H; Saunders J; Mostafa HH; Avery RK
    Open Forum Infect Dis; 2022 Jun; 9(6):ofac064. PubMed ID: 35663288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal Antibody Therapy of Breastfeeding Patient Infected with SARS-CoV-2: A Case Report.
    Marshall NE; Blanton MB; Doratt BM; Malherbe DC; Rincon M; Messaoudi I
    Breastfeed Med; 2023 Aug; 18(8):626-630. PubMed ID: 37615569
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
    Mazzaferri F; Mirandola M; Savoldi A; De Nardo P; Morra M; Tebon M; Armellini M; De Luca G; Calandrino L; Sasset L; D'Elia D; Sozio E; Danese E; Gibellini D; Monne I; Scroccaro G; Magrini N; Cattelan A; Tascini C; ; Tacconelli E
    Elife; 2022 Nov; 11():. PubMed ID: 36413383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
    Ravani P; Bonanni A; Rossi R; Caridi G; Ghiggeri GM
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):710-20. PubMed ID: 26585985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.